Escalier Biosciences Competitors and Similar CompaniesClear all
AOBiome's competitors and similar companies include MABION and Rallybio.
 AOBiome AOBiome is a pioneer in bacterial therapy.
We represent a new approach to skin health that focuses on the restoring good bacteria to your biome |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Rallybio Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins. | |
Founding Date | Founding Date 2013 | Founding Date 2007 | Founding Date 2018 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Konstantynów Łódzki, PL HQ | Locations New Haven, US HQ Farmington, US |
Employees | Employees 16 | Employees 95 | Employees 28 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 21.7 m | Valuation ($) 43.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) $858k (FY, 2025) |
Net income | Net income N/A | Net income (zł62.6m) (FY, 2025) | Net income ($9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 38.7m | Total funding raised N/A | Total funding raised $ 182m |
For sources of this data, please see the company profile
View Company Profiles
MABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companyRallybio
HQ
New Haven, US
Employees
28
Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins.
View company